Form 8-K - Current report:
SEC Accession No. 0001213900-24-034182
Filing Date
2024-04-18
Accepted
2024-04-18 17:23:20
Documents
14
Period of Report
2024-04-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204215-8k425_redwoods.htm   iXBRL 8-K 73064
  Complete submission text file 0001213900-24-034182.txt   306965

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rwod-20240412.xsd EX-101.SCH 3685
3 XBRL DEFINITION FILE rwod-20240412_def.xml EX-101.DEF 27225
4 XBRL LABEL FILE rwod-20240412_lab.xml EX-101.LAB 37384
5 XBRL PRESENTATION FILE rwod-20240412_pre.xml EX-101.PRE 25841
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0204215-8k425_redwoods_htm.xml XML 7323
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Redwoods Acquisition Corp. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 24855095
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)